Solventum Corp (NYSE: SOLV) develops healthcare solutions spanning wound care, dental, and advanced materials, following its spin-off from 3M. The company combines clinical expertise with manufacturing scale to deliver medical and surgical products used globally. Solventum’s shares move with hospital utilization trends, cost-efficiency initiatives, and its ability to drive growth as a focused, standalone healthcare enterprise.
最新股票文章

平頭哥分拆上市分析:阿里巴巴AI芯片業務的結構性風險與估值框架
阿里巴巴旗下平頭哥半導體擬分拆獨立上市,摩根大通估值介於250億至620億美元。本文從業務依賴度、估值方法論、地緣政策風險及港股科技板塊估值溢價等維度,解構該交易的結構性風險與分析框架。
14:16, 11 3月 2026


